Q3 2017 Earnings Forecast for Ekso Bionics Holdings, Inc. (EKSO) Issued By SunTrust Banks
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) – Investment analysts at SunTrust Banks raised their Q3 2017 earnings estimates for Ekso Bionics Holdings in a note issued to investors on Monday. SunTrust Banks analyst B. Nudell now forecasts that the company will post earnings of ($0.13) per share for the quarter, up from their prior forecast of ($0.15). SunTrust Banks also issued estimates for Ekso Bionics Holdings’ FY2017 earnings at ($0.64) EPS, FY2018 earnings at ($0.32) EPS and FY2021 earnings at ($0.17) EPS.
Ekso Bionics Holdings (NASDAQ:EKSO) last issued its quarterly earnings results on Tuesday, May 9th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.03. The company had revenue of $1.44 million for the quarter, compared to the consensus estimate of $2.38 million. Ekso Bionics Holdings had a negative return on equity of 798.93% and a negative net margin of 372.20%.
Several other brokerages have also recently issued reports on EKSO. Zacks Investment Research cut Ekso Bionics Holdings from a “buy” rating to a “hold” rating in a research report on Friday, June 16th. B. Riley restated a “buy” rating and issued a $4.00 price target on shares of Ekso Bionics Holdings in a research report on Wednesday, May 10th.
Ekso Bionics Holdings (NASDAQ:EKSO) opened at 1.84 on Thursday. The stock’s market cap is $47.17 million. Ekso Bionics Holdings has a 12 month low of $0.99 and a 12 month high of $6.38. The firm’s 50-day moving average price is $2.02 and its 200-day moving average price is $2.67.
Institutional investors have recently added to or reduced their stakes in the company. National Planning Corp boosted its position in Ekso Bionics Holdings by 116.2% in the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after buying an additional 126,000 shares during the last quarter. Carl Domino Inc boosted its position in Ekso Bionics Holdings by 74.7% in the second quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after buying an additional 35,088 shares during the last quarter. Finally, Independence Advisors LLC acquired a new position in Ekso Bionics Holdings during the second quarter valued at about $1,840,000. Institutional investors own 4.55% of the company’s stock.
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.